FDA clears J&J's chemotherapy for certain soft tissue sarcomas
(Reuters) - The U.S. Food and Drug Administration said it approved Johnson & Johnson's chemotherapy to treat specific soft-tissue sarcomas (STS) that have spread to other parts of the body or cannot be removed by surgery.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Chemotherapy | Food and Drug Administration (FDA) | Health | Sarcomas | Soft Tissue Sarcoma